Literature DB >> 2750829

Posterior chamber intraocular lens insertion during pars plana lensectomy and vitrectomy for complications of proliferative diabetic retinopathy.

G W Blankenship1, H W Flynn, G T Kokame.   

Abstract

We inserted posterior chamber lenses into 21 eyes with complications of diabetic retinopathy upon completion of pars plana lensectomy and vitrectomy in a single session. After the original surgery, two eyes developed retinal detachments and underwent vitrectomy revisions with scleral buckling, one eye had a fluid-gas exchange for residual vitreous cavity blood, one eye had supplemental laser treatment, and one eye had intraocular antibiotics for endophthalmitis. Six months later, postoperative vision was better in 16 of the 21 eyes (76%), the same in four eyes (19%), and worse in one eye (5%). In 16 eyes visual acuity was 20/200 or better, and in six eyes it was 20/40 or better postoperatively. Decreased vision was caused by preexisting macular disease; two eyes had corneal edema with iris neovascularization associated with residual retinal detachment. The procedure and lenses were well tolerated and provided good pseudophakic vision.

Entities:  

Mesh:

Year:  1989        PMID: 2750829     DOI: 10.1016/s0002-9394(14)73251-9

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  10 in total

1.  Intraocular silicone lenses in silicone oil: an experimental study.

Authors:  U Stolba; S Binder; M Velikay; A Wedrich
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-01       Impact factor: 3.117

Review 2.  [Surgical treatment of diabetic retinopathy and maculopathy].

Authors:  A M Joussen; H Llacer; J Mazciewicz; B Kirchhof
Journal:  Ophthalmologe       Date:  2004-12       Impact factor: 1.059

3.  Deposition of silicone oil droplets in the residual anterior lens capsule after vitrectomy and lensectomy in rabbits.

Authors:  T Miyamoto; S Saika; A Yamanaka; Y Okada; Y Ohnishi
Journal:  Br J Ophthalmol       Date:  2004-05       Impact factor: 4.638

4.  Combined lensectomy, vitrectomy, and primary intraocular lens implantation in patients with traumatic eye injury.

Authors:  Alexandre Assi; Charbel Bou Chacra; Georges Cherfan
Journal:  Int Ophthalmol       Date:  2007-10-26       Impact factor: 2.031

5.  Topical exposure of mitomycin C reduces opacification of the residual anterior lens capsule and lenticular regeneration after vitrectomy and lensectomy in rabbits.

Authors:  Takeshi Miyamoto; Shizuya Saika; Yuka Okada; Iku Ishida-Nishikawa; Takayoshi Sumioka; Norihito Fujita; Yoshitaka Ohnishi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-01-10       Impact factor: 3.117

6.  Predictors of postoperative bleeding after vitrectomy for vitreous hemorrhage in patients with diabetic retinopathy.

Authors:  Saori Motoda; Nobuhiko Shiraki; Takuma Ishihara; Hirokazu Sakaguchi; Daijiro Kabata; Mitsuyoshi Takahara; Takekazu Kimura; Junji Kozawa; Akihisa Imagawa; Kohji Nishida; Ayumi Shintani; Hiromi Iwahashi; Iichiro Shimomura
Journal:  J Diabetes Investig       Date:  2018-01-16       Impact factor: 4.232

7.  Surgical results of triamcinolone assisted pars plana vitrectomy combined with phacoemulsification in diabetic patients.

Authors:  Hakki Birinci
Journal:  Open Ophthalmol J       Date:  2008-01-30

8.  Intraoperative intravitreal triamcinolone decreases macular edema after vitrectomy with phacoemulsification.

Authors:  D Wilkin Parke; Robert A Sisk; Timothy G Murray
Journal:  Clin Ophthalmol       Date:  2012-08-17

9.  Ocular hypertension after intravitreal triamcinolone with vitrectomy and phacoemulsification.

Authors:  D Wilkin Parke; Robert A Sisk; Samuel K Houston; Timothy G Murray
Journal:  Clin Ophthalmol       Date:  2012-06-18

10.  The outcomes and prognostic factors of vitrectomy in chronic diabetic traction macular detachment.

Authors:  Muneera A Abunajma; Hassan Al-Dhibi; Emad B Abboud; Yahya Al Zahrani; Essam Alharthi; Abdullah Alkharashi; Nicola G Ghazi
Journal:  Clin Ophthalmol       Date:  2016-08-26
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.